We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESL.L Regulatory News (ESL)

  • There is currently no data for ESL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues outlook on CREALOGIX Group (CLXN)

21 Nov 2018 15:29

Edison Investment Research Limited Edison issues outlook on CREALOGIX Group (CLXN) 21-Nov-2018 / 15:29 GMT/BST


London, UK, 21 November 2018

Edison issues outlook on CREALOGIX Group (CLXN)

CREALOGIX (CLXN) has established a strong track record of delivering software solutions to the banking industry in Switzerland and is transitioning the business to international markets. FY18 numbers were below expectations, mainly due to the faster than anticipated switch to SaaS, which spreads out revenue. International revenues represent 57% of the total (50% in FY17). CREALOGIX acquired the 80% remainder of Elaxy BS&S in July, have acquired Innofis to target the Middle Eastern markets earlier this year. The stable, cash-generative nature of Elaxy BS&S balances the higher-risk, stronger growth profile of Innofis. Given the attractive industry dynamics, and with CREALOGIX ideally positioned to capitalise on these, the shares look attractive on c 21x our FY20e EPS.

A DCF scenario incorporating 10% organic revenue CAGR over 2019-29e falling thereafter to 2%, operating margins tapering up to a level of 15% from FY22e, along with a 9% WACC, would suggest a valuation of CHF217, 68% above the current share price. Increasing the margin target to 20% lifts the valuation to CHF284, while reducing the margin to 10% cuts it to CHF150. These valuations are after the dilution impact from the outstanding convertible bonds.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Richard Jeans, +44 (0)20 3077 5700Katherine Thompson, +44 (0)20 3077 5730tech@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

749693 21-Nov-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
9th Feb 20219:41 amRNSChange of Name to Logistics Development Group plc
15th Jan 20219:05 amRNSSecond Price Monitoring Extn
15th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20216:24 pmRNSHolding(s) in Company
5th Jan 20212:49 pmRNSHolding(s) in Company
31st Dec 202011:06 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
31st Dec 202010:20 amRNSDirector/PDMR Shareholding
30th Dec 202011:30 amRNSSchedule One Update - Eddie Stobart Logistics PLC
29th Dec 20203:24 pmRNSResults of General Meeting
29th Dec 20207:00 amRNSResult of Open Offer
14th Dec 20201:00 pmRNSSchedule One - Eddie Stobart Logistics plc
9th Dec 20209:05 amRNSSecond Price Monitoring Extn
9th Dec 20209:00 amRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSProposed conversion to Investing Company
8th Dec 20204:41 pmRNSSecond Price Monitoring Extn
8th Dec 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20209:00 amRNSPrice Monitoring Extension
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
24th Nov 20202:22 pmRNSResponse to share price movement
24th Nov 202011:05 amRNSSecond Price Monitoring Extn
24th Nov 202011:00 amRNSPrice Monitoring Extension
10th Nov 202011:06 amRNSSecond Price Monitoring Extn
10th Nov 202011:00 amRNSPrice Monitoring Extension
12th Oct 20202:06 pmRNSSecond Price Monitoring Extn
12th Oct 20202:00 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSTrading Update of Associate Company
28th Sep 20205:11 pmRNSFurther re General Meeting
28th Sep 20207:00 amRNSInterim Results for six months ended 31 May 2020
8th Sep 20207:00 amRNSNotice of General Meeting
25th Aug 20207:00 amRNSDirectorate Change
21st Aug 20207:00 amRNSSubstantial Contract Win by Associate Company
17th Aug 20207:00 amRNSTiming of Interim Results & Annual Report posting
6th Aug 20207:00 amRNSTrading Update of Associate Company
6th Jul 20207:00 amRNSFull Year Results 2019
8th Jun 202011:06 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSResult of AGM
21st May 20202:06 pmRNSSecond Price Monitoring Extn
21st May 20202:00 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSBrand Acquisition and Trading Update
11th May 20203:30 pmRNSClarification re date of Annual General Meeting
7th May 20204:24 pmRNSCompany Update & Notice of Annual General Meeting
3rd Apr 20207:00 amRNSDirectorate Update
24th Mar 202011:00 amRNSPrice Monitoring Extension
24th Mar 20207:01 amRNSHolding(s) in Company
24th Mar 20207:00 amRNSEddie Stobart statement regarding COVID-19
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.